ZEALAND PHARMA A/S (ZEAL) Financial Statements
ZEALAND PHARMA A/S (ZEAL) files with the U.S. Securities and Exchange Commission under CIK 0001674988. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2021
- Revenue
- 292.57 million DKK
- Net Income
- -1.02 billion DKK
- Total Assets
- 2.07 billion DKK
- Net Cash from Operations
- -1.21 billion DKK
Fiscal year ended Dec 31, 2021. Latest periodic SEC filing: Apr 5, 2022. Source: SEC filings (EDGAR XBRL). Amounts in DKK.
Open the full financial statements for ZEAL in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History